20 June 2024 - Agreement includes access to any future licence extensions. ...
6 June 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...
28 March 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...
6 February 2024 - Knight Therapeutics announced today the launch of Bijuva (oestradiol and progesterone) capsules in Canada. ...
31 January 2024 - In partnership with Sumitomo, Pfizer is proud to announce that supply of Myfembree (relugolix 40 mg, estradiol ...
18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab ...
21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the ...
11 January 2024 - A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be ...
29 November 2023 - NICE has published final evidence-based recommendations on the use of foslevodopa with foscarbidopa (Produodopa) for the ...
3 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
24 July 2023 - New Brunswick lists Albrioza on its drug benefit formulary, becoming the fourth province to provide public ...
19 July 2023 - Amylyx Pharmaceuticals Canada announced today that the Company has entered into a Product Listing Agreement with British ...
11 July 2023 - In an out of session consideration, the PBAC has recommended changes to the restriction criteria and eligible ...
28 June 2023 - Ontario lists Albrioza on its drug benefit formulary, becoming the first province to publicly reimburse Albrioza, ...
14 June 2023 - SMC has collaborated with NICE on Technology Appraisal, TA900: tixagevimab-cilgavimab for preventing COVID-19. ...